Ionis Pharmaceuticals (IONS) EBT Margin Growth (5y) (2014 - 2026)

Ionis Pharmaceuticals (IONS) EBT Margin Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Ionis Pharmaceuticals 9.21 Bn 7.29 Bn 243.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4,290.00
Dec 31, 2025 -40,978.00
Sep 30, 2025 -6,222.00
Jun 30, 2025 644,944.00
Mar 31, 2025 -7,185.00
Dec 31, 2024 18,807.00
Sep 30, 2024 -12,176.00
Jun 30, 2024 25,293.00
Mar 31, 2024 -20,073.00
Dec 31, 2023 4,077.00
Sep 30, 2023 10,149.00
Jun 30, 2023 663.00
Mar 31, 2023 -5,054.00
Dec 31, 2022 -465.00
Sep 30, 2022 -2,371.00
Jun 30, 2022 -7,434.00
Mar 31, 2022 -5,289.00
Dec 31, 2021 -1,218.00
Sep 30, 2021 -6,957.00
Jun 30, 2021 8,434.00